Shuttle Pharmaceuticals Holdings (SHPH) Long-Term Debt Repayments (2024)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Long-Term Debt Repayments of $345139.0 for Q3 2024.
Shuttle Pharmaceuticals Holdings (SHPH) Long-Term Debt Repayments (2024) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at $345139.0 for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -156,847.56 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 345,139.00 |
| Sep 30, 2024 | 345,139.00 |